HSCS HeartSciences Inc Forecast, Technical & Fundamental Analysis
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease... Show more
HSCS is expected to report earnings to rise 37.25% to -69 cents per share on September 10
Q3'26
Est.
$-0.70
Q2'26
Missed
by $0.52
Q4'25
Missed
by $0.81
Q3'25
Missed
by $1.54
Q2'25
Missed
by $1.93
The last earnings report on July 22 showed earnings per share of -50 cents, missing the estimate of 0 cents. With 94.38K shares outstanding, the current market capitalization sits at 10.92M.
A.I.dvisor tells us that HSCS and HSDT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSCS and HSDT's prices will move in lockstep.
HSCS's RSI Indicator climbs into overbought territory
The RSI Oscillator for HSCS moved into overbought territory on August 21, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The 10-day moving average for HSCS crossed bearishly below the 50-day moving average on August 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSCS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HSCS broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HSCS entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 17, 2026. You may want to consider a long position or call options on HSCS as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HSCS just turned positive on August 18, 2026. Looking at past instances where HSCS's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
HSCS moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HSCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HSCS's P/B Ratio (48.544) is slightly higher than the industry average of (11.035). P/E Ratio (0.549) is within average values for comparable stocks, (70.949). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.006). HSCS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). HSCS's P/S Ratio (1666.667) is very high in comparison to the industry average of (34.463).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSCS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
